Are you Dr. Ngarmchamnanrith?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5501 Old York Rd
Suite 363
Philadelphia, PA 19141Phone+1 215-456-7890
Summary
- Dr. Gataree Ngarmchamnanrith, MD is an oncologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in California.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2005 - 2008
Chulalongkorn University Faculty of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2009 - 2023
Publications & Presentations
PubMed
- 160 citationsSotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASmutation: a randomised, open-label, phase 3 trial.Adrianus Johannes de Langen, Melissa L Johnson, Julien Mazieres, Anne-Marie C Dingemans, Giannis Mountzios
Lancet. 2023-03-04 - 132 citationsSotorasib inp.G12C-Mutated Advanced Pancreatic Cancer.John H Strickler, Hironaga Satake, Thomas J George, Rona Yaeger, Antoine Hollebecque
The New England Journal of Medicine. 2023-01-05 - 137 citationsSotorasib for previously treated colorectal cancers with KRASmutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial.Marwan G Fakih, Scott Kopetz, Yasutoshi Kuboki, Tae Won Kim, Pamela N Munster
The Lancet. Oncology. 2022-01-01
